STERILE COMPOUNDING: WHAT’S THE HAZARD? USP 800 REVIEW

The pharmacist’s knowledge of USP 800 guidance is critical for safe drug handling in all pharmacy practice settings. The USP 800 guidance will become effective December 2019. The information provided in this CE will assist pharmacists in protecting patients, themselves, and other healthcare providers from hazardous drugs. This course will provide an overview of USP 800 and the NIOSH list of hazardous drugs. Further, participants can expect to review proper handling of hazardous drugs according to USP 800 and to discuss how to develop a plan to safe handling of hazardous drugs at their practice site.

This module (1.0 CE), along with the other three MCPHS sterile compounding CE modules, ‘Parenteral Nutrition CSPs-2020 Update’ (2.0 CE), ‘History and Basics – Aseptic Technique USP 797, 2019/20’ (1.5 CE), and ‘503b Outsourcing Facilities’ (0.5 CE), total to 5.0 credits of sterile compounding. 

Learning Objectives

Upon completion of this activity, the participant should be able to:

-Outline the USP 800 regulation and importance across all practice sites.

-Identify potentially hazardous drugs using the NIOSH list.

-Demonstrate proper handling of hazardous drugs.

-Develop a plan for safe handling of hazardous drugs at your site.

-Educate other healthcare professionals on the safe handling of hazardous drugs.